Dendritic cell immune receptor activator, method for activating dendritic cell immune receptor, osteoclast formation inhibitor, method for inhibiting osteoclast formation, dendritic cell differentiation/proliferation inhibitor, method for inhibiting dendritic cell differentiation/proliferation, cytokine production inhibitor, method for inhibiting cytokine production, therapeutic method and screening method
US10792300B2 · kind B2 · utility
1Cited by
2References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 10, 2015 |
| Grant date | Oct 6, 2020 |
| Priority date | — |
| Expiry date | Jul 10, 2035 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A dendritic cell immune receptor activator, comprising a compound having a sugar chain as an active ingredient, the sugar chain having a basic structure represented by the following formula:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.